Today: 21 May 2026
Snowflake stock price slips after hours; here’s what Wall Street is watching next
27 February 2026
1 min read

Snowflake stock price slips after hours; here’s what Wall Street is watching next

New York, Feb 26, 2026, 18:26 EST — After-hours

  • Snowflake dropped 1.9% in after-hours trading, wiping out a 2.3% gain from Thursday’s regular session.
  • Fourth-quarter product revenue jumped 30%, while contracted backlog surged.
  • Guidance beat forecasts, yet signaled growth is cooling, with investors zeroing in on AI demand and margins.

Snowflake Inc shares dropped 1.9% after the bell on Thursday, erasing some of their earlier advance as investors digested the company’s outlook alongside new AI-related deals.

These shifts are significant: Snowflake’s consumption-based setup means revenue tracks closely with customer activity. The stock often acts as a real-time indicator of corporate IT budgets—particularly now, as more firms shift workloads into AI projects.

Guidance and backlog now matter just as much as the quarter’s numbers. Investors are looking for clear signs that AI demand is driving genuine platform activity—not just generating hype and test runs.

Snowflake shares ended the session at $173.06, a 2.28% gain. After the bell, they slipped to $169.75. In regular trading, the stock moved between $167.20 and $184.42.

Fourth-quarter revenue hit $1.28 billion, according to a regulatory filing on Wednesday. Product revenue, the line most directly reflecting platform usage, climbed to $1.23 billion. Both figures marked a 30% jump from a year ago. Remaining performance obligations—contracted but unrecognized revenue—surged 42% to $9.77 billion. Net revenue retention clocked in at 125%. “The promise of AI became real,” CEO Sridhar Ramaswamy said. CFO Brian Robins cited 740 net new customers for the quarter. SEC

Snowflake is projecting fiscal 2027 product revenue of $5.66 billion, beating Wall Street’s consensus of $5.50 billion, though it’s guiding for product revenue growth to moderate at 27% for both Q1 and the full year, LSEG data show. CEO Ramaswamy told Reuters that more than 2,500 customers now use the company’s Snowflake Intelligence “agentic” platform—software that acts on users’ behalf—and mentioned Snowflake’s biggest contract yet, valued at over $400 million, but didn’t identify the client. D.A. Davidson’s Gil Luria said, “Investors are skeptical about all software companies right now.” Snowflake also revealed two separate multi-year $200 million deals with OpenAI and Anthropic, and confirmed a $600 million acquisition of app-monitoring platform Observe. Investing.com

The forecast’s slowdown takes the air out of the narrative. Snowflake might post solid results, yet shares could swing sharply—customers could clamp down on usage, or AI-related workloads might drive expenses above projections.

Traders are watching for evidence that these new partnerships actually drive consistent consumption. There’s also the question of whether the Observe integration might end up disrupting sales execution or pressuring margins.

Snowflake’s top brass are set to take the stage at the Morgan Stanley Technology, Media & Telecom Conference on March 3, with their presentation locked in for 4:05 p.m. PT. Investors will be watching for updates on AI demand, margin trends, and news on the Observe deal.

Stock Market Today

  • Sensex nudges up as oil prices drop and rupee strengthens
    May 21, 2026, 3:46 AM EDT. Indian shares edged higher on Thursday, with the BSE Sensex up 0.20% and the Nifty 50 gaining 0.30%. The rise followed a decline in Brent crude oil prices, which dipped 5.6% near $106 a barrel, and a rebound in the rupee supported by Reserve Bank of India dollar sales. Despite early gains fading, investor sentiment improved amid easing inflation pressures and stabilizing currency. Key earnings influenced moves, with Apollo Hospitals posting a 36% profit increase and Lenskart Solutions reporting 46% revenue growth. Caution persisted over Ola Electric due to a 5% revenue decline. Market momentum depends on crude oil trends and rupee stability as investors balance earnings strength against macroeconomic challenges like high U.S. bond yields.

Latest articles

Fed Officials Float Rate Hikes Again as Cut Hopes Wobble

Fed Officials Float Rate Hikes Again as Cut Hopes Wobble

21 May 2026
Federal Reserve minutes released Wednesday showed most officials see possible rate hikes if inflation remains above 2%. Markets and economists have pushed back expectations for rate cuts, with some now anticipating increases. The Fed’s benchmark rate held at 3.50% to 3.75% in April. The next FOMC meeting is set for June 16-17.
Treasury yields close in on 2007 highs, Wall Street takes note

Treasury yields close in on 2007 highs, Wall Street takes note

21 May 2026
The 30-year U.S. Treasury yield reached 5.128% early Thursday, near its highest level since 2007, with the 10-year at 4.593%. Treasury data showed the 30-year par yield at 5.11% Wednesday, down from 5.18% Tuesday. The average 30-year fixed U.S. mortgage rate rose to 6.56%, the highest in seven weeks, as mortgage applications fell 2.3%. Fed minutes showed most policymakers see more tightening if inflation stays above 2%.
Asia Chips Rally Lifts Nvidia, Samsung Shares

Asia Chips Rally Lifts Nvidia, Samsung Shares

21 May 2026
Asian stocks jumped Thursday, led by chipmakers after Nvidia forecast stronger revenue and Samsung Electronics reached a deal to avert a strike. MSCI’s Asia-Pacific index outside Japan rose 2.6%, with South Korea’s KOSPI up over 7% and Samsung shares nearly 8% higher. SK Hynix surged 11.3%. Japan’s exports climbed 14.8% in April, but its services PMI fell to 50.0, ending more than a year of growth.
Intuit stock drops after hours as TurboTax maker flags heavier tax-season spending
Previous Story

Intuit stock drops after hours as TurboTax maker flags heavier tax-season spending

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal
Next Story

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal

Go toTop